GemPharmatech (688046.SH) shareholder Qingdao National Pharmaceutical reduced its holdings by 888,200 shares, decreasing its stake to 5%.
Yaokang Biopharmaceuticals (688046.SH) announced that on September 24, 2024, the company's shareholder, Qingdao Guoyao Daichuang...
GemPharmatech (688046.SH) announced on September 24, 2024, that its shareholder Qingdao Guoyao DaChuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao Guoyao") has reduced its shareholding in the company by 888,200 shares through block trading, accounting for 0.22% of the total share capital of the company. After this equity change, Qingdao Guoyao holds a reduced stake of 5% in the company.
Related Articles
Hunan Silver (002716.SZ) director Rongqi resigns
Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.
China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
Hunan Silver (002716.SZ) director Rongqi resigns
Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.
China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
